中国基层医药
中國基層醫藥
중국기층의약
CHINESE JOURNAL OF PRIMARY MEDICINE AND PHARMACY
2010年
5期
589-590
,共2页
肝硬化%中西医结合
肝硬化%中西醫結閤
간경화%중서의결합
Liver cirrhosis%Mtegrated traditional chinese and western medicine%Therapy
目的 探讨中西医结合治疗肝硬化腹水的临床疗效. 方法 80例肝硬化腹水患者按中西医结合治疗(A组)和单纯西医治疗(B组);A组40例除常规对症治疗,另予活血化瘀、软坚散结、滋养肝肾中药方剂;B组40例仅采用常规治疗方法. 结果 A组总有效率85.0%高于B组75.0%(X~2=3.86,P<0.05);两组治疗前后各指标比较有统计学意义(t=2.312,t=2.247,t=2.801,t=2.847,P<0.05～0.01);A、B组治疗后TBA、ALT、PTA组间比较有统计学意义(t=2.812,t=2.247,t=2.301,P<0.05～0.01);A组腹水消退后稳定时间(45.26±6.38)d明显优于B组(31.76±6.58)d(t=2.314,P<0.05);A组1个月、2个月、6个月内复发低于B组(X~2=3.89,X~2=3.96,X~2=4.01,P均<0.05). 结论 中西医结合治疗肝硬化腹水能有效改善肝功能,调节机体免疫,降低门脉高压,使腹水消退.
目的 探討中西醫結閤治療肝硬化腹水的臨床療效. 方法 80例肝硬化腹水患者按中西醫結閤治療(A組)和單純西醫治療(B組);A組40例除常規對癥治療,另予活血化瘀、軟堅散結、滋養肝腎中藥方劑;B組40例僅採用常規治療方法. 結果 A組總有效率85.0%高于B組75.0%(X~2=3.86,P<0.05);兩組治療前後各指標比較有統計學意義(t=2.312,t=2.247,t=2.801,t=2.847,P<0.05～0.01);A、B組治療後TBA、ALT、PTA組間比較有統計學意義(t=2.812,t=2.247,t=2.301,P<0.05～0.01);A組腹水消退後穩定時間(45.26±6.38)d明顯優于B組(31.76±6.58)d(t=2.314,P<0.05);A組1箇月、2箇月、6箇月內複髮低于B組(X~2=3.89,X~2=3.96,X~2=4.01,P均<0.05). 結論 中西醫結閤治療肝硬化腹水能有效改善肝功能,調節機體免疫,降低門脈高壓,使腹水消退.
목적 탐토중서의결합치료간경화복수적림상료효. 방법 80례간경화복수환자안중서의결합치료(A조)화단순서의치료(B조);A조40례제상규대증치료,령여활혈화어、연견산결、자양간신중약방제;B조40례부채용상규치료방법. 결과 A조총유효솔85.0%고우B조75.0%(X~2=3.86,P<0.05);량조치료전후각지표비교유통계학의의(t=2.312,t=2.247,t=2.801,t=2.847,P<0.05～0.01);A、B조치료후TBA、ALT、PTA조간비교유통계학의의(t=2.812,t=2.247,t=2.301,P<0.05～0.01);A조복수소퇴후은정시간(45.26±6.38)d명현우우B조(31.76±6.58)d(t=2.314,P<0.05);A조1개월、2개월、6개월내복발저우B조(X~2=3.89,X~2=3.96,X~2=4.01,P균<0.05). 결론 중서의결합치료간경화복수능유효개선간공능,조절궤체면역,강저문맥고압,사복수소퇴.
Objective To study clinical effect of Chinese medicine and western medicine in treating hepatocirrhosis ascites.Method 80 cases with hepatocirrhosis ascites were randomly divided into combination therapy group(A group)40 cases and simple western medicine treatment group(B group)40 cases;A group were treated with symptomatic treatment plus promote blood flow to removing blood stasis.soften hard lumps and dispel nodes and nourishing liver and kidney drugs,B group of control were treated with conventional therapy.Results Total effective rate in A group was 85.0%which was higher than B group 75.0%(X~2=3.86,P<0.05).The indicators have more significant difference in two groups before and after treatment(t=2.312,t=2.247,t=2.801,t=2.847,P<0.05～0.01);The contents of TBA、ALT and PTA in A、B group after treatment have more significant difference(t=2.812,t=2.247,t=2.301,P<0.05～0.01);The time of ascites subsided after the settling in A group(45.26±6.38)days,significantly better than the B group(31.76±6.58)days(t=2.314,P<0.05);The recurrence of within 1month、within 2 months、within 6 months in A group were lower than B group(X~2=3.89,X~2=3.96,X~2=4.01,P all <0.05).Conclusion The combined Chinese medicine and western medicine can improve liver function,regulate organism immunization,cut down portal hypertension to resolve hepatocirrhosis ascites.
